| Artigo em revista |
- Mesquita, Katia Almeida. "Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1
deficient epithelial ovarian cancers.". Theranostics (2021): https://europepmc.org/articles/PMC8344016.
10.7150/thno.51456
- Mesquita, Katia Almeida. "FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers.".
Cancers (2021): https://europepmc.org/articles/PMC8070745.
10.3390/cancers13081866
- Magalhães-Novais, Silvia; Bermejo-Millo, Juan C.; Loureiro, Rute; Mesquita, Katia A.; Domingues, M. Rosário; Maciel, Elisabete;
Melo, Tânia; et al. "Cell quality control mechanisms maintain stemness and differentiation potential of P19 embryonic carcinoma
cells". Autophagy 16 2 (2020): 313-333. http://dx.doi.org/10.1080/15548627.2019.1607694.
10.1080/15548627.2019.1607694
- Ali, Reem; Alabdullah, Muslim; Alblihy, Adel; Miligy, Islam; Mesquita, Katia A.; Chan, Stephen YT.; Moseley, Paul; Rakha,
Emad A.; Madhusudan, Srinivasan. "PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers".
Cancer Letters 469 (2020): 124-133. http://dx.doi.org/10.1016/j.canlet.2019.10.035.
10.1016/j.canlet.2019.10.035
- Abdel-Fatah, Tarek M. A.; Ali, Reem; Sadiq, Maaz; Moseley, Paul M.; Mesquita, Katia A.; Ball, Graham; Green, Andrew R.; et
al. "ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers".
Cancers 11 8 (2019): 1149. http://dx.doi.org/10.3390/cancers11081149.
10.3390/cancers11081149
- Mesquita KA; Alabdullah M; Griffin M; Toss MS; Fatah TMAA; Alblihy A; Moseley P; et al. "ERCC1-XPF deficiency is a predictor
of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.". Gynecologic oncology
(2019): http://europepmc.org/abstract/med/30797591.
10.1016/j.ygyno.2019.02.014
- Reem Ali; Abdulbaqi Al-Kawaz; Michael S. Toss; Andrew R. Green; Islam M. Miligy; Katia A. Mesquita; Claire Seedhouse; et al.
"Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic
Lethality and Chemoprevention". Cancer Research 78 24 (2018): 6818-6827. https://doi.org/10.1158/0008-5472.CAN-18-0633.
10.1158/0008-5472.CAN-18-0633
- Ali, Reem; Al-Kawaz, Abdulbaqi; Toss, Michael S.; Green, Andrew R.; Miligy, Islam M.; Mesquita, Katia A.; Seedhouse, Claire;
et al. "Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces
Synthetic Lethality and Chemoprevention". Cancer Research 78 24 (2018): 6818-6827. http://dx.doi.org/10.1158/0008-5472.can-18-0633.
10.1158/0008-5472.can-18-0633
- Loureiro, Rute; Mesquita, Katia A.; Magalhães-Novais, Silvia; Oliveira, Paulo J.; Vega-Naredo, Ignacio. "Mitochondrial biology
in cancer stem cells". Seminars in Cancer Biology 47 (2017): 18-28. http://dx.doi.org/10.1016/j.semcancer.2017.06.012.
10.1016/j.semcancer.2017.06.012
- Loureiro R; Magalhães-Novais S; Mesquita KA; Baldeiras I; Sousa IS; Tavares LC; Barbosa IA; Oliveira PJ; Vega-Naredo I. "Melatonin
antiproliferative effects require active mitochondrial function in embryonal carcinoma cells.". (2015): http://europepmc.org/abstract/med/26025920.
- Vega-Naredo, I; Loureiro, R; Mesquita, K A; Barbosa, I A; Tavares, L C; Branco, A F; Erickson, J R; et al. "Mitochondrial
metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells". Cell Death and Differentiation
21 10 (2014): 1560-1574.
Publicado • 10.1038/cdd.2014.66
- Loureiro, Rute; A. Mesquita, Katia; J. Oliveira, Paulo; Vega-Naredo, Ignacio. "Mitochondria in Cancer Stem Cells: A Target
for Therapy". Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 7 2 (2013): 102-114.
Publicado • 10.2174/18722148113079990006
- Inácio, Ângela S.; Mesquita, Katia A.; Baptista, Marta; Ramalho-Santos, João; Vaz, Winchil L. C.; Vieira, Otília V.; Covas,
Dimas Tadeu. "In Vitro Surfactant Structure-Toxicity Relationships: Implications for Surfactant Use in Sexually Transmitted
Infection Prophylaxis and Contraception". PLoS ONE 6 5 (2011): e19850-e19850.
Publicado • 10.1371/journal.pone.0019850
|
